ELISA / EIA / RIA Kits · ELISA / EIA kit · Cat. EK-011-17
BNP-45 (Rat) – EIA Kit
Supplied as 96 wells per unit. Species: Rat. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | EK-011-17 |
|---|---|
| Product type | ELISA / EIA / RIA Kits · ELISA / EIA kit |
| Peptide family | Brain Natriuretic Peptide (BNP) |
| Species | Rat |
| Unit size | 96 wells |
| Sensitivity | 0.3 ng/ml |
| Specificity | Peptide % BNP-45 (Rat) 100 BNP-32(Rat) 100 BNP-45 (Mouse) 11.3 BNP-32 (Porcine) 0 BNP-26 (Porcine) 0 BNP-32 (Human) 0 BNP-32 (Canine) 0 ANP (Rat) 0 a-ANP (1-28) (Human, Canine) 0 Endothelin-1 0 Angiotensin II (Human) 0 |
| Linear Range | 0.3 - 4.73 ng/ml |
| Inter-Assay CV | <15% |
| Intra-Assay CV | <10% |
| Standard Curve | Contact us for technical specifications on this product. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms. Deres L, Bartha E, Palfi A, et al. PLoS ONE. 2014;9(7):e102148. Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function. Szymanski MK, Buikema JH, Van veldhuisen DJ, et al. Basic Res Cardiol. 2012;107(2):242. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. Angelini A, Castellani C, Ravara B, et al. J Heart Lung Transplant. 2011;30(11):1281-93. Characterization of cardiac size and function in SHRSP.Z-Lepr(fa)/IzmDmcr rats, a new animal model of metabolic syndrome. Tada Y, Kagota S, Matsumoto M, et al. Biol Pharm Bull. 2010;33(12):1971-6. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats. Van esch JH, Moltzer E, Van veghel R, et al. J Hypertens. 2010;28(10):2145-55. Gene expression of ANP, BNP and ET-1 in the heart of rats during pulmonary embolism. Gutte H, Oxbøl J, Kristoffersen US, Mortensen J, Kjaer A. PLoS ONE. 2010;5(6):e11111. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats. Bartha E, Solti I, Kereskai L, et al. J. Cardiovasc Res. 2009;83(3):501-10. Expression of B-type natriuretic peptide-45 (BNP-45) gene in the ventricular myocardial induced by systemic chronic hypoxia. Ferdinal F, Suyatna FD, Wanandi SI, Sadikin M. Acta Med Indones. 2009;41(3):136-43. Bartha et al. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure. J Cardiovasc Pharmacol. 2008 Sep;52(3):253-61. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. Palfi et al. J Mol Cell Cardiol. 2006 Jul;41(1):149-59. Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. Szabó C. Pharmacol Res. 2005;52(1):34-43. |
| Sample Extraction | Recommended |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Frequently asked
What is BNP-45 (Rat) – EIA Kit?
BNP-45 (Rat) – EIA Kit is a elisa / eia kit elisa / eia / ria kit listed under catalog number EK-011-17 in the Brain Natriuretic Peptide (BNP) family, rat sequence. It is supplied as 96 wells per unit for in vitro laboratory research.
What is the intended use of EK-011-17?
This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.